Development of supramolecular anticoagulants with on-demand reversibility
Springer Nature Sustainability Community,
Have you ever wanted to target a specific protein but the therapeutic window seemed too risky?
Have you ever wanted to target a specific protein but the therapeutic window seemed too risky?
Researchers have developed a new type of anticoagulant whose action can be rapidly stopped. This ‘on-demand’ reversible…
Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis.